These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33520909)

  • 1. The Experience of Implementing a National Antimicrobial Resistance Surveillance System in Brazil.
    Pillonetto M; Jordão RTS; Andraus GS; Bergamo R; Rocha FB; Onishi MC; de Almeida BMM; Nogueira KDS; Dal Lin A; Dias VMCH; de Abreu AL
    Front Public Health; 2020; 8():575536. PubMed ID: 33520909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017.
    Liu C; Yoon EJ; Kim D; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Kim HS; Kim YR; Jeong SH
    J Infect Chemother; 2019 Nov; 25(11):845-859. PubMed ID: 31311694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Gales AC; Pfaller MA; Mendes RE; Zoccoli C; Barth A; Jones RN
    Braz J Infect Dis; 2001 Aug; 5(4):200-14. PubMed ID: 11712965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
    Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FREQUENCY AND ANTIMICROBIAL SUSCEPTIBILITY OF PATHOGENS AT TERTIARY PUBLIC HOSPITAL, SAO PAULO, BRAZIL.
    Prestes-Carneiro LE; Azevedo AM; Nakashima MA; Xavier JM; Cabral C
    Southeast Asian J Trop Med Public Health; 2015 Mar; 46(2):276-84. PubMed ID: 26513931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers.
    Sader HS; Sampaio JL; Zoccoli C; Jones RN
    Braz J Infect Dis; 1999 Apr; 3(2):63-79. PubMed ID: 11098193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z; Chen M; Yu Y; Pan S; Liu Y
    Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study.
    Sirijatuphat R; Chayangsu S; Srisompong J; Ruangkriengsin D; Thamlikitkul V; Tiengrim S; Wangchinda W; Koomanachai P; Rattanaumpawan P
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013.
    Vu TVD; Do TTN; Rydell U; Nilsson LE; Olson L; Larsson M; Hanberger H; Choisy M; Dao TT; van Doorn HR; Nguyen VK; Nguyen VT; Wertheim HFL;
    J Glob Antimicrob Resist; 2019 Sep; 18():269-278. PubMed ID: 31201995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteriuria.
    Sirijatuphat R; Pongsuttiyakorn S; Supapueng O; Kiratisin P; Thamlikitkul V
    J Glob Antimicrob Resist; 2020 Mar; 20():60-67. PubMed ID: 31751803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia.
    Sirijatuphat R; Sripanidkulchai K; Boonyasiri A; Rattanaumpawan P; Supapueng O; Kiratisin P; Thamlikitkul V
    PLoS One; 2018; 13(1):e0190132. PubMed ID: 29298323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges of antimicrobial resistance in Brazil.
    Rossi F
    Clin Infect Dis; 2011 May; 52(9):1138-43. PubMed ID: 21467020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.
    Sader HS; Jones RN; Andrade-Baiocchi S; Biedenbach DJ;
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):273-80. PubMed ID: 12493175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of de-duplication methods used by WHO Global Antimicrobial Resistance Surveillance System (GLASS) and Japan Nosocomial Infections Surveillance (JANIS) in the surveillance of antimicrobial resistance.
    Kajihara T; Yahara K; Stelling J; Eremin SR; Tornimbene B; Thamlikitkul V; Hirabayashi A; Anzai E; Wakai S; Matsunaga N; Hayakawa K; Ohmagari N; Sugai M; Shibayama K
    PLoS One; 2020; 15(6):e0228234. PubMed ID: 32589639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.